Sino-Agri Leading BiosciencesLtd Past Earnings Performance
Past criteria checks 2/6
Sino-Agri Leading BiosciencesLtd has been growing earnings at an average annual rate of 15.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.6% per year. Sino-Agri Leading BiosciencesLtd's return on equity is 14.1%, and it has net margins of 2.1%.
Key information
15.1%
Earnings growth rate
15.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 17.6% |
| Return on equity | 14.1% |
| Net Margin | 2.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Sino-Agri Leading BiosciencesLtd (SHSE:603970) Seems To Use Debt Quite Sensibly
Sep 27
Benign Growth For Sino-Agri Leading Biosciences Co.,Ltd (SHSE:603970) Underpins Stock's 25% Plummet
Jul 15Sino-Agri Leading BiosciencesLtd's (SHSE:603970) Shareholders May Want To Dig Deeper Than Statutory Profit
May 02Revenue & Expenses Breakdown
How Sino-Agri Leading BiosciencesLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 10,610 | 218 | 344 | 71 |
| 30 Jun 24 | 10,706 | 231 | 339 | 66 |
| 31 Mar 24 | 10,514 | 228 | 337 | 72 |
| 31 Dec 23 | 10,460 | 225 | 348 | 65 |
| 30 Sep 23 | 10,380 | 223 | 305 | 68 |
| 30 Jun 23 | 11,890 | 224 | 303 | 60 |
| 31 Mar 23 | 12,007 | 219 | 297 | 48 |
| 31 Dec 22 | 11,699 | 210 | 297 | 46 |
| 30 Sep 22 | 11,032 | 202 | 279 | 39 |
| 30 Jun 22 | 10,039 | 198 | 276 | 38 |
| 31 Mar 22 | 9,036 | 180 | 254 | 37 |
| 31 Dec 21 | 8,822 | 170 | 247 | 38 |
| 30 Sep 21 | 8,933 | 162 | 247 | 40 |
| 30 Jun 21 | 7,978 | 152 | 238 | 37 |
| 31 Mar 21 | 7,102 | 138 | 248 | 36 |
| 31 Dec 20 | 6,641 | 132 | 239 | 34 |
| 30 Sep 20 | 6,119 | 130 | 241 | 31 |
| 30 Jun 20 | 5,260 | 125 | 234 | 31 |
| 31 Mar 20 | 4,521 | 120 | 220 | 33 |
| 31 Dec 19 | 4,342 | 119 | 226 | 31 |
| 30 Sep 19 | 4,195 | 121 | 237 | 11 |
| 30 Jun 19 | 4,015 | 121 | 236 | 13 |
| 31 Mar 19 | 3,850 | 120 | 236 | 12 |
| 31 Dec 18 | 3,735 | 115 | 237 | 12 |
| 30 Sep 18 | 3,561 | 109 | 248 | 15 |
| 30 Jun 18 | 3,573 | 106 | 251 | 11 |
| 31 Mar 18 | 3,629 | 96 | 271 | 5 |
| 31 Dec 17 | 3,503 | 90 | 268 | 4 |
| 30 Sep 17 | 3,489 | 88 | 267 | 0 |
| 31 Dec 16 | 3,398 | 82 | 271 | 0 |
| 31 Dec 15 | 3,234 | 88 | 258 | 0 |
| 31 Dec 14 | 2,875 | 81 | 238 | 0 |
| 31 Dec 13 | 2,488 | 69 | 211 | 0 |
Quality Earnings: 603970 has high quality earnings.
Growing Profit Margin: 603970's current net profit margins (2.1%) are lower than last year (2.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603970's earnings have grown by 15.1% per year over the past 5 years.
Accelerating Growth: 603970's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 603970 had negative earnings growth (-2.3%) over the past year, making it difficult to compare to the Chemicals industry average (-3.6%).
Return on Equity
High ROE: 603970's Return on Equity (14.1%) is considered low.